BRO:NYE-Brown & Brown Inc (USD)

COMMON STOCK | Insurance Brokers |

Last Closing

USD 105.83

Change

+0.79 (+0.75)%

Market Cap

N/A

Volume

1.61M

Analyst Target

USD 46.56
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Insurance Brokers

Symbol Name Price(Change) Market Cap
AON Aon PLC

-1.48 (-0.40%)

USD 80.22B
AJG Arthur J Gallagher & Co

-0.64 (-0.22%)

USD 62.57B
CRD-B Crawford & Company

-0.10 (-0.86%)

USD 0.56B
CRD-A Crawford & Company

+0.05 (+0.44%)

USD 0.56B
SLQT Selectquote Inc

-0.01 (-0.50%)

USD 0.34B
MMC Marsh & McLennan Companies Inc

-0.67 (-0.30%)

N/A

ETFs Containing BRO

GFGF Guru Favorite Stocks ETF 5.01 % 0.00 %

+0.09 (+0.29%)

USD 0.03B
MDCP VictoryShares THB Mid Cap.. 4.00 % 0.00 %

-0.18 (0.29%)

USD 0.11B
VMIN:AU Vanguard Global Minimum V.. 1.51 % 0.00 %

N/A

USD 0.01B
CZA Invesco Zacks Mid-Cap ETF 0.00 % 0.65 %

+0.09 (+0.29%)

N/A
DTN 0.00 % 0.38 %

N/A

N/A
PXMG 0.00 % 0.39 %

N/A

N/A
FCTR:LSE 0.00 % 0.00 %

N/A

N/A
USMF:LSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance Brokers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -62.79% 29% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.79% 29% F 12% F
Trailing 12 Months  
Capital Gain -61.82% 29% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.82% 29% F 11% F
Trailing 5 Years  
Capital Gain -29.69% 17% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.69% 17% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 19.24% 86% B+ 81% B-
Dividend Return 20.01% 86% B+ 80% B-
Total Return 0.76% 17% F 18% F
Risk Return Profile  
Volatility (Standard Deviation) 23.38% 57% F 46% F
Risk Adjusted Return 85.56% 71% C- 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.